TNF-α, a key cytokine, plays a significant role in autoimmune diseases, with TNF-α inhibitors revolutionizing their treatment [143]; they achieve this by impairing insulin signalling by increasing the serine phosphorylation of insulin receptor substrates, leading to decreased insulin sensitivity [144]. Here, INSR is linked to autoimmune disease.